Cytokine release syndrome as a consequence of check point inhibitors nivolimumab and iplimumab

Authors : Amrita Shah, Pradeep Rangappa, Ipe Jacob, Karthik Rao, Neelesh Reddy

DOI : 10.18231/j.ijpo.2022.096

Volume : 9

Issue : 4

Year : 2022

Page No : 392-394


 


Citation Data


Related Articles

Renal replacement lipomatosis - A rare but also underdiagnosed entity

Jyotsana Khatrri, Madhvi Sanwalka, Sumit Gupta, Niyati Sakarwal, Seema Awasthi

Combination of forsus fatigue resistant device and premolar extraction for the management of a skeletal class II malocclusion

Nausheer Ahmed, Aravinda V N, Rithika Joseph*, K Ranjan R Bhat

An analytical study on the performance of the banking ombudsman scheme in India

Riya Rupani, Shaukat Ali

Awareness of diabectic retinopathy among diabetics in urban population of Hyderabad, South India

Nirupama Damarla*, Sanjay Reddy Tadisina, Hymavathi Bommisetti, Satyanarayana Reddy Geedipally, Madhavi Chevuturu

Biodegradable polymeric nanoparticles: An overview

Suryakanta Swain, Debashish Ghose

The ICH guidelines in practices: Stress degradation studies on botulinum toxin and validation of developed stability-indicating HPLC method

Sonal Bhale

Role of intradialytic oral nutrition therapy in Indian patients

Raksha Goyal, Nandini Sarwate

Management of kissing nevus of eyelid by radiofrequency ablation: A case report

Urmil Chawla, A K Khurana, Monika Dahiya, Gunjan Chadha, Bhawna Khurana, Tejal Bidhalan, Akanksha Rani

Ophthalmological practices in COVID times

Prerna Sinha, Amit Raj*, Amit Kumar, Upasna Sinha